SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Use of the novel antifungal rezafungin in outpatient parenteral antibiotic therapy: early experience from a single centre

Davidson, H; Dunstan, I; Yau, T; Houston, A; Basarab, M; Bicanic, T (2025) Use of the novel antifungal rezafungin in outpatient parenteral antibiotic therapy: early experience from a single centre. In: Infection 2024: BSAC Winter Conference, JAC-ANTIMICROBIAL RESISTANCE, 5 December 2024, London.
SGUL Authors: Bicanic, Tihana Davidson, Harriet Claire

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (60kB) | Preview
Item Type: Conference or Workshop Item (UNSPECIFIED)
Additional Information: © The Author(s) 2025. Published by Oxford University Press on behalf of British Society for Antimicrobial Chemotherapy. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: JAC-ANTIMICROBIAL RESISTANCE
Article Number: dlae217.004
ISSN: 2632-1823
Publisher License: Creative Commons: Attribution 4.0
Web of Science ID: WOS:001404877500001
URI: https://openaccess.sgul.ac.uk/id/eprint/117116
Publisher's version: https://doi.org/10.1093/jacamr/dlae217.004

Actions (login required)

Edit Item Edit Item